# A Study to Evaluate the Effectiveness of NuvaRing® to Prevent Pregnancies in Chinese Women (P06450)

> **NCT01277211** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 983 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** ENG 120 µg + EE 15 µg intravaginal ring
- **DRUG:** DRSP 3 mg + EE 30 µg

## Key facts

- **NCT ID:** NCT01277211
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09-19
- **Primary completion:** 2013-09-18
- **Final completion:** 2013-09-18
- **Target enrollment:** 983 (ACTUAL)
- **Last updated:** 2024-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01277211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01277211, "A Study to Evaluate the Effectiveness of NuvaRing® to Prevent Pregnancies in Chinese Women (P06450)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01277211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*